Xencor Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
/ 
Frequently asked questions
To buy Xencor Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Xencor Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Xencor Inc. is XNCR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Xencor Inc. has its primary listing on NASDAQ. You can trade Xencor Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Xencor Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Xencor Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Xencor Inc..